In this study, we synthesized and characterized the antibacterial activity of three naturally occurring oxyprenylated chalcones {xinjiachalcone A (1), (3), and lawsone 2-isopentenyl ether (4)}. Using several strains of Helicobacter pylori, including clinical ones, minimum inhibitory concentration (MIC) values and bactericidal activities of these compounds were determined. Xinjiachalcone A (1), active principle of Glycyrrhiza inflata Batalin, was the most effective compound, showing both a low MIC and a strong bactericidal activity against H. pylori. This study suggests that these compounds represent potential natural molecules for the prevention and treatment of H. pylori associated diseases.
Prenylation is either the chemical or enzymatic addition of a terpenyl moiety to an accepting molecule (for example, another terpenoid, an aromatic compound, a protein). This biochemical reaction occurs in plant families like Rutaceae, Asteraceae, Apiaceae, Guttiferae, Fabaceae, and others, comprising several edible fruits and vegetables [1] [2] . Thus oxyprenylated natural products represent compounds of mixed origin for which the final step of the biosynthetic process is the prenylation of an alkaloid or a phenylpropanoid / polyketide core. Considering the length of the carbon chain, three types of prenyloxy skeletons can be classified: C5 (isopentenyl), C10 (geranyl) and C15 (farnesyl). To date, about 350 oxyprenylated derivatives have been isolated and/or synthesized and were shown to possess a wide range of valuable and promising pharmacological activities [1] [2] .
Helicobacter pylori infects more than half of the worldwide human population and is the major cause of gastroduodenal pathologies including gastritis, ulcer disease, gastric cancer, and mucosaassociated lymphoid tissue (MALT) lymphoma [3] [4] . Eradication of the infection reverses gastric lesions and, more importantly, prevents the associated-severe pathologies at early stages. Accordingly, in humans, several randomized and non-randomized studies show regression of precancerous lesions as compared with control groups, after H. pylori eradication [5] [6] . This was also confirmed in hypergastrinemic INS-GAS mice, a model of gastric carcinogenesis [7] . H. pylori eradication in these animals significantly reduced the severity of gastric dysplasia induced by the infection. The classical treatment to eradicate H. pylori infection is represented by the combination of two antibiotics like amoxicilline, clarithromycine, or metronidazole, and a PPI, omeprazole with ≤ 80% cure [8] . However, failures of the antibacterial therapies have been reported in several studies due to a high incidence of antibiotic resistant strains, as high as 20% or more, depending on the country, as in the case of clarithromycine or metronidazole [10] [11] . Then, quadruple therapy options including two antibiotics, PPI, and bismuth have recently been proposed [9] . Thus, the search for alternative therapies based on the use of new compounds with antibacterial activity is of current and increasing interest.
In this context we recently reported that some oxyprenylated secondary metabolites, namely oxyprenylated cinnamic acids and cinnamaldehydes from the Australian shrub Boronia pinnata Sm. (Rutaceae), exert an effective in vitro and in vivo growth inhibitory effect against different strains of H. pylori [12] [13] . In this work, we characterized the in vitro antibacterial activity of three naturally occurring oxyprenylated chalcones, namely xinjiachalcone A (1), isolated from the roots of Glycyrrhiza inflata Batalin (Fam. Fabaceae) [14] ,
, obtained from Helichrysum, Pleiotaxis, and Metalasia spp. [15] [16] [17] , and finally lawsone 2-isopentenyl ether (4), extracted from the fungus Streptocarpus dunnii [18] . MICs of compounds for seventeen H. pylori strains are reported in Table 1 . Clarithromycin, an antibiotic commonly used in the eradication of H. pylori, was used as reference drug. The MICs of compound 4 were 50 µM for 10 strains and 25 µM for 7 strains. MIC 50 and MIC 90 were 50 µM. In order to investigate better the effects of these compounds, the kinetics of their bactericidal activities were determined at a final concentration of 100 µM on the three H. pylori strains HP141, CCUG 38772 and J99 during a period of 70 min. for compound 1, 2 h for compound 2, and finally 80 min. for compound 3 (Figure 1 ).
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Compounds 1 and 3 killed all the bacterial inoculums of the three strains in time periods varying from 30 min to 90 min. A higher variability of the bactericidal kinetics was observed for compound 2; this caused a 3 log reduction of the strain J99 after 2 h of incubation and 100% mortality of the strains CCUG and HP141 after incubation times of 30 and 90 min, respectively. Despite the differences observed in the sensitivity between the bacterial strains treated with compound 2 in bactericidal activity tests, all the strains showed MIC values higher than 200. This may be due either to instability of the compound during the long time of incubation required for bacterial growth or an interaction of this compound with the CSA medium. Compound 4 exhibited no significant bactericidal activity after 2 h of incubation suggesting a bacteriostatic activity in the tested conditions (data not shown). Compound 4 showed MIC values close to those of compound 1, which is bactericidal; this suggests that these two compounds may have different mechanisms of action. Taken together, these results suggest that compound 1 exhibits the most promising antibacterial activity, showing both a low MIC and a strong bactericidal activity against H. pylori.
The serious gastric diseases associated with H. pylori infection still constitute a public health threat in several part of the world. The current situation in terms of H. pylori resistance to antibiotics makes difficult the treatment of diseases caused by this bacterium. Consequently, efforts should be directed toward finding alternative and novel anti-H. pylori agents. Our study provided new information on oxyprenylated chalcones and naphthoquinone indicating that they possess interesting antimicrobial properties that may be useful for the prevention and treatment of H. pyloriassociated diseases. Studies to define better the pharmacological profile of the compounds under investigation, as well as to depict the mechanism of action underlying the observed effects are now ongoing in our laboratories. (3), and the naphthoquinone lawsone 2-isopentenyl ether (4) were chemically synthesized following already described procedures [19] [20] . Compounds were dissolved in dimethyl sulfoxide (DMSO) at final concentration of 100 mM. Subsequent dilutions of the stock solutions were made in water.
Experimental

Chemicals: The chalcones xinjiachalcone
Bacterial strains and culture:
The H. pylori reference strains used throughout the study were J99, 26695, B128, CCUG 38772, AG1 and B38. In addition, eleven H. pylori clinical strains isolated at the University Hospital of Poitiers were used: HP 141, PGA1-5 (gastritis associated); PDU1-4 (duodenal ulcer associated) and PMA1 (MALT associated 
MIC determination by agar dilution method:
On the day of use, the compounds were serially diluted in sterile water to give final concentrations from 200 to 1.56 μM and were added to the CSA plates at less than 50°C. Each H. pylori strain was suspended at a concentration of 10 9 cells/mL in sterile saline. A Steers replicator was used to deliver approximately 1 μL of each bacterial suspension onto CSA plates with compounds. A compound-free plate was inoculated at the beginning and end of each series of plates to confirm the viability of the inoculum and to observe the growth of any contaminants. The plates were incubated under microaerobic conditions at 35°C for 72 h. The MIC was determined as the lowest concentration of the compound that completely inhibited visible bacterial growth of the tested H. pylori strains after the incubation period.
